Cullen Capital Management, LLC Merck & Co., Inc. Transaction History
Cullen Capital Management, LLC
- $9.2 Billion
- Q3 2024
A detailed history of Cullen Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cullen Capital Management, LLC holds 2,051,656 shares of MRK stock, worth $204 Million. This represents 2.53% of its overall portfolio holdings.
Number of Shares
2,051,656
Previous 1,593,766
28.73%
Holding current value
$204 Million
Previous $197 Million
18.08%
% of portfolio
2.53%
Previous 2.33%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,829Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.52 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.87 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $251B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...